Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants-Reference-Cited by-同舟云学术

Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants

Published:2023-04-06 Issue:6 Volume:24 Page:747-762
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Principi Nicola¹,Autore Giovanni²,Perrone Serafina³,Esposito Susanna²^ORCID

Affiliation:

1. Università degli Studi di Milano, Milan, Italy

2. Pediatric Clinic, Pietro Barilla Children’s Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy

3. Neonatology Unit, Pietro Barilla Children’s Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2197590

Reference164 articles.

1. Prevalence and Risk Factors of Respiratory Syncytial Virus in Children under 5 Years of Age in the WHO European Region: A Systematic Review and Meta-Analysis

2. Social, economic, and health impact of the respiratory syncytial virus: a systematic search

3. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States

4. Centers for Disease Control and Prevention. Respiratory Syncytial Virus (RSV) Surveillance. Available at: https://www.cdc.gov/surveillance/nrevss/rsv/index.html Accessed on Dec 12, 2022.

5. European Center for Disease Prevention and Control. RSV virus expected to add pressure on hospitals in many EU/EEA countries this season. Available at: https://www.ecdc.europa.eu/en/news-events/rsv-virus-expected-add-pressure-hospitals-many-eueea-countries-season Accessed on Nov 30, 2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in hospitalizations of children with respiratory syncytial virus aged less than 1 year in Italy, from 2015 to 2019;Italian Journal of Pediatrics;2024-06-21

2. Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use;Drugs & Therapy Perspectives;2023-12